Скачать или смотреть Risks of Non-Compliance in Non-Clinical GLP Studies | GxP Quality Insights

Non-compliance in non-clinical GLP studies can have serious consequences, from regulatory findings and study invalidation to delays in product development.

In this episode of RiverArk’s Quality Insights series, we discuss the key risks associated with GLP non-compliance in non-clinical studies, drawing on real-world quality and regulatory experience. The conversation explores common compliance pitfalls, the impact of inadequate systems and oversight, and how organisations can strengthen their approach to Good Laboratory Practice (GLP) to protect data integrity and inspection outcomes.

This video is designed for quality assurance professionals, study directors, regulatory leaders, and life sciences organisations involved in non-clinical research who want to reduce risk and maintain regulatory confidence.

🔍 Topics include:
• Risks and consequences of GLP non-compliance
• Common findings in non-clinical GLP studies
• Data integrity and quality system challenges
• Regulatory expectations for GLP environments
• Best practices to reduce compliance risk

Subscribe to RiverArk for expert insights into GxP compliance, quality assurance, auditing, and inspection readiness across the life sciences industry.

#QualityInsights #GLPCompliance #NonClinicalStudies #GxPCompliance #LifeSciences